Published in Hospital Law Weekly, November 16th, 2006
Investigators in Turkey report, "Fontan operation and its modifications are used for the physiological correction of complex congenital heart malformations with functionally single ventricle. Atrial natriuretic peptide (ANP), a physiological diuretic and vasodilator that - together with the effects of cardiopulmonary bypass - plays an important role in the augmentation of capillary permeability in Fontan patients. The rise in right atrial pressure and wall stress...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.